Hepatitis C Virus
New Hepatitis C Virus Research from Y. Itoh and Co-Researchers Described
Published in Hepatitis Weekly, April 25th, 2011
2011 APR 25 -- "We advocate a simple formula which can conveniently predict the outcome of Peg-interferon (IFN) alpha2b and ribavirin (RBV) combination therapy for genotype 1 chronic hepatitis C (CH-C) with high viral load. A total of 338 (group A: 230, Group B: 108) genotype 1 CH-C patients treated with Peg-IFN alfa-2b and RBV were enrolled," scientists writing in the journal Hepatology Research report.
"Clinical parameters differing significantly between sustained virological responders (SVRs) and non-SVRs in group A were categorized, then a simple formula to predict SVR was constructed and re-evaluated in group B. Another formula containing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2011-04-25)
More Articles from Hepatitis Weekly
- Cirrhosis
Data on Cirrhosis Discussed by Researchers at University of Sydney - Viral RNA
Data on Viral RNA Reported by B. Zhang and Co-Researchers - Hepatitis B Virus
Investigators at University of Bologna Have Published New Data on Hepatitis B Virus - Hepatitis B Virus
New Findings in Hepatitis B Virus Described from Military Medical College - Genetics and Hepatitis C Virus
New Genetics and Hepatitis C Virus Research from Y.P. Li et al Outlined - Hepatitis B Virus
New Hepatitis B Virus Data Have Been Reported by Y.S. Chang and Co-Authors - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
